Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 437
Appendix A Statement of Task The Institute of Medicine (IOM) will convene an ad hoc committee to study the evolving global epidemic of cardiovascular disease (CVD) and offer conclusions and recommendations pertinent to its control and to a range of public- and private-sector entities involved with global health and development. The proposed study should take advantage of the concept frameworks of the 1998 IOM report, the 2004 Earth Institute/IC Health Report, the 2007 “Grand Challenges” report, and a series of global cardiovascular health declarations (Victoria 1992, Catalonia 1995, Singapore 1998, Victoria 2000, Osaka 2001, and Milan 2004). It should synthesize and expand relevant evidence and knowledge based on findings from research and development, with an emphasis on developing pertinent concepts of global partnership and collaborations, and recommending actions targeted at global governmental organizations, nongovernmental organizations, policy and decision makers, funding agencies, academic and research institutions, and the general public. The study should draw upon the rich experience and best practices learned from global collaborations and infrastructure efforts to combat infectious diseases. An emphasis should be placed on multidirectional learning—best practices in one region of the world which can inform multiple other regions and, importantly, lessons learned from global practices that can inform the delivery and practice of medicine in the United States. It is expected that the report of this definitive, didactic, and scientific study will present, to the extent that evidence permits, sound arguments and reasoning for increasing investment in global cardiovascular health promotion and CVD prevention and control. The re-
OCR for page 438
port should serve to help initiate global dialogue, align global forces, draw public attention, and lead to concerted global and international actions. The specific aims of the study are as follows: Define the magnitude of the global CVD epidemic by examining, analyzing, and determining the burden of, and trends in, CVD worldwide. Identify current status, capacities, and best practices in CVD prevention and management in developed and developing countries, and determine how these best practices may be applied to other regions with an emphasis on multidirectional learning. Identify elements of success in global public health collaborations and infrastructure development learned from addressing infectious diseases that can be extended to the chronic, noncommunicable diseases. Examine specific gaps and barriers in implementing effective CVD prevention programs. Review existing frameworks and develop a global platform of actions and priorities (including research and development, prevention programs, and training) that may provide health systems (at the global, regional, country, and local levels) and settings (community, school, workplace, and health care), policy makers, and individuals with a specific set of goals and objectives, and performance measures (metrics). Identify current and potential future opportunities for collaboration and partnerships that will better enable individuals, organizations, or countries to enhance their capacities to address cardiovascular health. Develop strategies to enhance global, regional, and international partnerships. Identify and recommend the knowledge and tools that will be needed by individuals, organizations, and countries to anticipate, prevent, recognize, mitigate, and respond to the CVD epidemic. Develop an evaluation plan for monitoring the progress of global actions.